Xaira's X-Cell Model Unlocks Data Scaling Limits
Xaira Therapeutics demonstrates how overcoming information gaps in biological data unlocks scaling walls for AI drug discovery. By leveraging rich datasets like the 168M-cell CELLxGENE database, their virtual cell initiatives prove that information-dense data generation is just as vital as parameter scaling.
Source: Latent Space